NephroGenex, Inc. OMNIBUS AGREEMENT AND CONSENTOmnibus Agreement and Consent • January 10th, 2014 • NephroGenex, Inc. • Pharmaceutical preparations
This Omnibus Agreement and Consent is entered into as of January __, 2014, among NephroGenex, Inc., a Delaware corporation (the “Company”), and the undersigned holders of the Company’s common stock, par value $0.001 (the “Common Stock”), the undersigned holders of the Company’s Series A preferred stock, par value $0.001 (the “Series A Preferred Stock”), and the undersigned holders of the Company’s convertible promissory notes (the “Convertible Notes”). The undersigned holders of the Common Stock, Series A Preferred Stock and Convertible Notes are collectively referred to herein as the “Holders”.
